Speedier treatment and better outcomes for high volume stroke centers

May 9, 2012

Treatment is faster and outcomes are better at stroke centres dealing with a high volume of , finds research published online in the Journal of NeuroInterventional Surgery.

The authors base their findings on 442 patients treated with endovascular therapy—clot busting treatment provided inside the brain via a catheter without the need for surgery—at nine specialist (tertiary) stroke centres between September 2009 and July 2011.

All the patients, whose average age was 66, arrived at the centres within eight hours of the start of their symptoms. They all had a blood clot in a major brain artery, which had cut off blood supply and caused their stroke.

The researchers collected information on age and sex, and risk factors likely to affect the success of treatment, such as high blood pressure, abnormal heart rhythms (atrial fibrillation), diabetes, and high cholesterol.

They also looked at other key factors, including the size and location of the clot, the time taken before treatment was given, and how quickly blood flow was restored (reperfusion).

The data showed that the average time to the start of treatment—insertion of a catheter through the groin—after a CT scan of the brain, and injection of the clot buster drug into the affected artery, to completion of the procedure, was 95 minutes, on average.

The researchers then looked at whether the stroke centres were high volume facilities, defined as carrying out more than 50 such procedures a year.

Around half the patients (49%) were treated in under 95 minutes, with most of these (80%) treated at high volume centres; the remaining 20% were treated at low volume centres.

Looking only at patients referred from within the hospital, only 20 of the 112 patients treated at the low volume centres would have met the recommended 120 minute door to needle time, which is considered essential for boosting the chances of survival.

This compares with 40 out of 100 patients referred from within the hospital at high volume treatment centres.

Just over half (52%) of patients were transferred from another hospital. Although there was no difference in overall procedure times between them and those referred from within the same facility, they did start their treatment sooner.

A higher proportion of patients from other facilities were referred to a high volume centre, where they were more likely to be given clot-busting drugs, and to receive faster for each of the steps involved.

They were 86% more likely to survive and 82% more likely to have blood flow successfully restored in the affected artery. Delays in reperfusion are critical: for every 30 minutes of delay, the chances of survival fall by 12%, say the authors.

"Centers that currently perform higher numbers of [endovascular stroke] procedures appear to have lower times to reperfusion, and a higher proportion of patients with successful , translating into improved ," they conclude.

Explore further: Clot-busting drugs appear safe for treating 'wake-up' stroke patients

More information: Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomes, Online First, doi 10.1136/neurintsurg-2011-010245

Related Stories

Clot-busting drugs appear safe for treating 'wake-up' stroke patients

February 1, 2012
Clot-busting drugs may be safe for patients who wake up experiencing stroke symptoms, according to preliminary research presented at the American Stroke Association's International Stroke Conference 2012.

New device performs better than old for removing blood clots

February 3, 2012
An experimental blood clot-removing device outperformed the FDA-approved MERCI; retriever device, according to late-breaking science presented at the American Stroke Association's 2012 International Stroke Conference.

Cholesterol drugs may improve blood flow after stroke

April 26, 2011
(Medical Xpress) -- Cholesterol-lowering drugs known as statins may help clot-busting drugs treat strokes, according to researchers at Washington University School of Medicine in St. Louis.

Recommended for you

World's first child hand transplant a 'success'

July 19, 2017
The first child in the world to undergo a double hand transplant is now able to write, feed and dress himself, doctors said Tuesday, declaring the ground-breaking operation a success after 18 months.

Knee surgery—have we been doing it wrong?

July 18, 2017
A team of University at Buffalo medical doctors have published a study that challenges a surgical practice used for decades during arthroscopic knee surgery.

New tools help surgeons find liver tumors, not nick blood vessels

July 17, 2017
The liver is a particularly squishy, slippery organ, prone to shifting both deadly tumors and life-preserving blood vessels by inches between the time they're discovered on a CT scan and when the patient is lying on an operating ...

Researchers discover indicator of lung transplant rejection

July 13, 2017
Research by scientists at Dignity Health St. Joseph's Hospital and Medical Center's Norton Thoracic Institute was published in the July 12, 2017 issue of Science Translational Medicine titled "Zbtb7a induction in alveolar ...

New device could make closing surgical incisions a cinch

July 7, 2017
Like many surgeons, Dr. Jason Spector is often faced with the challenge of securely closing the abdominal wall without injuring the intestines. If the process goes awry, there can be serious consequences for patients, including ...

Success with first 20 patients undergoing minimally invasive pancreatic transplant surgery

June 29, 2017
Surgeons at Johns Hopkins Medicine report that their first series of a minimally invasive procedure to treat chronic pancreas disease, known as severe pancreatitis, resulted in shorter hospital stays, less need for opioids ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.